Renaissance Technologies’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$351K Sell
791,978
-91,720
-10% -$40.7K ﹤0.01% 2986
2025
Q1
$500K Buy
883,698
+173,920
+25% +$98.4K ﹤0.01% 2744
2024
Q4
$1.5M Sell
709,778
-14,300
-2% -$30.2K ﹤0.01% 2235
2024
Q3
$1.95M Sell
724,078
-21,200
-3% -$57K ﹤0.01% 2038
2024
Q2
$2.12M Buy
745,278
+42,800
+6% +$122K ﹤0.01% 1851
2024
Q1
$2.98M Sell
702,478
-17,900
-2% -$75.9K ﹤0.01% 1772
2023
Q4
$3.85M Sell
720,378
-24,300
-3% -$130K 0.01% 1509
2023
Q3
$3.2M Sell
744,678
-7,529
-1% -$32.4K 0.01% 1563
2023
Q2
$4.13M Buy
752,207
+22,200
+3% +$122K 0.01% 1535
2023
Q1
$3.07M Sell
730,007
-4,300
-0.6% -$18.1K ﹤0.01% 1763
2022
Q4
$2.03M Sell
734,307
-117,159
-14% -$325K ﹤0.01% 2055
2022
Q3
$2.18M Sell
851,466
-149,796
-15% -$384K ﹤0.01% 1957
2022
Q2
$3.61M Buy
1,001,262
+52,817
+6% +$190K ﹤0.01% 1787
2022
Q1
$5.89M Buy
948,445
+42,500
+5% +$264K 0.01% 1470
2021
Q4
$6.39M Sell
905,945
-170,500
-16% -$1.2M 0.01% 1350
2021
Q3
$7.51M Sell
1,076,445
-156,900
-13% -$1.1M 0.01% 1206
2021
Q2
$10.3M Sell
1,233,345
-194,300
-14% -$1.62M 0.01% 1153
2021
Q1
$7.8M Buy
1,427,645
+211,200
+17% +$1.15M 0.01% 1355
2020
Q4
$5.22M Sell
1,216,445
-34,903
-3% -$150K 0.01% 1558
2020
Q3
$3.77M Buy
1,251,348
+219,218
+21% +$660K ﹤0.01% 1744
2020
Q2
$3.2M Buy
1,032,130
+355,300
+52% +$1.1M ﹤0.01% 1901
2020
Q1
$1.5M Buy
676,830
+140,830
+26% +$311K ﹤0.01% 2213
2019
Q4
$1.64M Buy
536,000
+20,788
+4% +$63.4K ﹤0.01% 2415
2019
Q3
$1.58M Sell
515,212
-385,788
-43% -$1.19M ﹤0.01% 2401
2019
Q2
$1.8M Buy
901,000
+279,500
+45% +$559K ﹤0.01% 2383
2019
Q1
$2.68M Sell
621,500
-78,410
-11% -$338K ﹤0.01% 2164
2018
Q4
$2.23M Sell
699,910
-179,790
-20% -$572K ﹤0.01% 2176
2018
Q3
$4.62M Buy
879,700
+132,232
+18% +$694K ﹤0.01% 1855
2018
Q2
$4M Sell
747,468
-9,831
-1% -$52.6K ﹤0.01% 1926
2018
Q1
$3.79M Buy
757,299
+145,167
+24% +$726K ﹤0.01% 1998
2017
Q4
$2.02M Buy
612,132
+7,087
+1% +$23.4K ﹤0.01% 2343
2017
Q3
$2.27M Buy
605,045
+15,045
+3% +$56.4K ﹤0.01% 2236
2017
Q2
$1.5M Buy
590,000
+29,500
+5% +$75.2K ﹤0.01% 2408
2017
Q1
$1.46M Buy
560,500
+31,300
+6% +$81.4K ﹤0.01% 2395
2016
Q4
$1.61M Buy
529,200
+20,500
+4% +$62.5K ﹤0.01% 2326
2016
Q3
$1.38M Sell
508,700
-25,500
-5% -$69.4K ﹤0.01% 2409
2016
Q2
$1.53M Sell
534,200
-23,300
-4% -$66.6K ﹤0.01% 2355
2016
Q1
$1.68M Sell
557,500
-9,300
-2% -$28.1K ﹤0.01% 2320
2015
Q4
$1.97M Sell
566,800
-34,300
-6% -$119K ﹤0.01% 2120
2015
Q3
$2.27M Sell
601,100
-23,900
-4% -$90.3K 0.01% 1916
2015
Q2
$3.56M Buy
625,000
+15,800
+3% +$90.1K 0.01% 1665
2015
Q1
$3.55M Buy
609,200
+9,481
+2% +$55.2K 0.01% 1581
2014
Q4
$3.4M Sell
599,719
-32,381
-5% -$184K 0.01% 1501
2014
Q3
$2.59M Sell
632,100
-108,300
-15% -$443K 0.01% 1535
2014
Q2
$3.37M Buy
740,400
+155,826
+27% +$709K 0.01% 1456
2014
Q1
$2.77M Buy
584,574
+95,374
+19% +$452K 0.01% 1589
2013
Q4
$2.3M Sell
489,200
-65,006
-12% -$305K 0.01% 1683
2013
Q3
$2.21M Buy
554,206
+67,495
+14% +$269K 0.01% 1613
2013
Q2
$1.73M Buy
+486,711
New +$1.73M ﹤0.01% 1658